Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Muscle Vibration as a Countermeasure Against Hypoactivity-induced

NCT: NCT07021079 · RECRUITING

NCT IDNCT07021079
StatusRECRUITING
Start Date2025-06-16
Completion2027-08-31

Brief Summary

Muscle deconditioning, characterized by a loss of muscle mass and strength, is a frequent consequence of prolonged lower limb unloading. Beyond muscle mass loss, reduced neural drive contributes significantly to strength decline, highlighting the need for interventions targeting neuromuscular function during immobilization. Focal muscle vibration (FMV) has shown promise in modulating neuromuscular excitability by activating muscle spindle afferents and inducing cortical adaptations. Chronic use of FMV has been associated with significant strength gains and improved neural command. This makes FMV an effective rehabilitation tool. Its simplicity and non-invasiveness further make it a practical countermeasure.

Frequently Asked Questions

What is Muscle Vibration as a Countermeasure Against Hypoactivity-induced?

Muscle Vibration as a Countermeasure Against Hypoactivity-induced is a clinical trial registered under NCT07021079. Current status: RECRUITING.

What is the status of NCT07021079?

The current status of NCT07021079 (Muscle Vibration as a Countermeasure Against Hypoactivity-induced) is: RECRUITING.

When did Muscle Vibration as a Countermeasure Against Hypoactivity-induced start?

Muscle Vibration as a Countermeasure Against Hypoactivity-induced started on 2025-06-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.